Skip to main content

Want a detailed portfolio tracker?

Verona Pharma (VRNA) Profit Margin (2021 - 2025)

Verona Pharma (VRNA) profit margin from Sep 30, 2021 to Jun 30, 2025. The current Verona Pharma (VRNA) profit margin is 11.56%. You can export chart.

Annual Profit Margin

Quarterly Profit Margin

Annual Profit Margin change of Verona Pharma (VRNA)

YearProfit MarginChange
2024-410.17%
-97.25%
2022-14934.78%
+10650.25%
2021-138.93%
N/A

Comparison Verona Pharma (VRNA) profit margin with competitors

Verona Pharma (VRNA) profit margin is 11.56%.

TickerNameProfit MarginUpside
OMEROmeros Corporation871.00%+7436.49%
PRTCPureTech Health plc American Depositary Shares793.00%+6761.58%
ABEOAbeona Therapeutics Inc454.90%+3836.11%
CHRSCoherus Biosciences Inc397.30%+3337.71%
INVAInnoviva Inc119.90%+937.46%
ZVRAZevra Therapeutics Inc101.60%+779.11%
ABUSArbutus Biopharma Corp94.73%+719.67%
SAVACassava Sciences Inc.93.68%+710.58%
GLPGGalapagos NV86.83%+651.31%
CTNMContineum Therapeutics Inc - Class A83.13%+619.30%
BDTXBlack Diamond Therapeutics Inc80.77%+598.88%
NEUPNeuphoria Therapeutics Inc75.08%+549.64%
IPSCCentury Therapeutics Inc70.13%+506.81%
FULCFulcrum Therapeutics Inc69.26%+499.28%
CVACCureVac N.V.68.44%+492.19%
PRTAProthena Corporation plc64.05%+454.20%
HCWBHCW Biologics Inc63.16%+446.50%
QTTBQ32 Bio Inc61.90%+435.60%
AVIRAtea Pharmaceuticals Inc60.95%+427.38%
ASNDAscendis Pharma A/S57.30%+395.80%
PLXProtalix BioTherapeutics Inc54.27%+369.58%
AGENAgenus Inc52.20%+351.67%
CGENCompugen Ltd48.57%+320.26%
KRYSKrystal Biotech Inc48.07%+315.93%
RPRXRoyalty Pharma plc - Class A46.73%+304.34%
XOMAPXOMA Corp45.90%+297.16%
XOMAOXOMA Corp45.90%+297.16%
AUPHAurinia Pharmaceuticals Inc44.21%+282.54%
NXTCNextcure Inc43.49%+276.31%
CPRXCatalyst Pharmaceuticals Inc42.66%+269.12%
HALOHalozyme Therapeutics Inc39.83%+244.64%
ADMAAdma Biologics Inc39.59%+242.56%
XOMAXOMA Corp36.25%+213.66%
VRTXVertex Pharmaceuticals Inc34.53%+198.78%
EXELExelixis Inc34.46%+198.17%
SLNOSoleno Therapeutics Inc33.17%+187.01%
CRMDCorMedix Inc30.29%+162.09%
TNGXTango Therapeutics Inc29.52%+155.43%
ARGXArgen X SE28.20%+144.01%
CAICaris Life Sciences Inc - Class A27.98%+142.10%
JAZZJazz Pharmaceuticals plc27.42%+137.26%
SPROSpero Therapeutics Inc24.90%+115.45%
INCYIncyte Corp23.83%+106.19%
REGNRegeneron Pharmaceuticals Inc20.17%+74.52%
NAGENiagen Bioscience Inc20.07%+73.66%
ICCCImmucell Corp18.75%+62.24%
NERVMinerva Neurosciences Inc17.79%+53.93%
ALNYAlnylam Pharmaceuticals Inc16.99%+47.01%
ENVBEnveric Biosciences Inc16.64%+43.98%
TECHBio-Techne Corp16.39%+41.82%
HRMYHarmony Biosciences Holdings Inc15.08%+30.48%
ONCBeiGene Ltd15.02%+29.96%
RIGLRigel Pharmaceuticals14.71%+27.28%
BMRNBiomarin Pharmaceutical Inc13.77%+19.15%
VXRTVaxart Inc13.20%+14.22%
IMCRImmunocore Holdings plc12.16%+5.22%
SVASinovac Biotech Ltd11.25%-2.66%
FBIOFortress Biotech Inc10.80%-6.55%
TGTXTG Therapeutics Inc9.65%-16.50%
PHARPharming Group N.V.7.76%-32.86%
APLSApellis Pharmaceuticals Inc6.95%-39.86%
PTGXProtagonist Therapeutics Inc6.71%-41.94%
NUVBNuvation Bio Inc - Class A6.48%-43.93%
FBIOPFortress Biotech Inc6.40%-44.62%
GMABGenmab5.92%-48.78%
SRPTSarepta Therapeutics Inc2.98%-74.22%
BMEABiomea Fusion Inc2.37%-79.49%
ACADAcadia Pharmaceuticals Inc1.36%-88.23%
FENCFennec Pharmaceuticals Inc1.33%-88.49%
FOLDAmicus Therapeutics Inc0.91%-92.13%
HOTHHoth Therapeutics Inc0.17%-98.53%
BBLGBone Biologics Corp0.02%-99.83%